Effect of Retama raetam on lipid metabolism in normal and recent-onset diabetic rats

Journal of Ethnopharmacology

Volumn 90, Issue 2-3, 2004, Pages 323-329

  Maghrani, M ^a   Lemhadri, A ^a   Zeggwagh, N A ^a   El Amraoui, A ^a   Haloui, M ^b   Jouad, H ^a   Eddouks, M ^a  

^a MOULAY ISMAIL UNIVERSITY   (Morocco)

^b BICHAT HOSPITAL   (France)

Author keywords

Aqueous extract and diabetic rats; Body weight; Cholesterol; Retama raetam; Triglycerides

Indexed keywords

ANTILIPEMIC AGENT; CHOLESTEROL; PLANT EXTRACT; RETAMA RAETAM EXTRACT; STREPTOZOCIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; WATER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; DRUG SCREENING; HYPERGLYCEMIA; LIPID METABOLISM; NONHUMAN; RAT; STREPTOZOCIN DIABETES; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT REDUCTION;

RETAMA RAETAM;

EID: 0842328612     PISSN: 03788741     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jep.2003.10.008     Document Type: Article

References (16)

1. Boulos, L., 1999. Flora of Egypt, vol.1. Azollacea-Oxalidaceae. Cairo, Egypt: Al-Hadara Publishing, pp. 258-259.
2. Burcelin R., Eddouks M., Maury J., Kande J., Assan R., Girard J. Excessive glucose production, rather than insulin resistance, accounts for hyperglycaemia in recent-onset streptozotocin-diabetic rats. Diabetologia. 38:1995;283-290.
3. DeFronzo R.A. Lilly lecture 1987: the triumvirate: B-cell, muscle, liver: a collusion responsible for NIDDM. Diabetes. 37:1988;667-687.
4. Eddouks, M., Maghrani, M., Lemhadri, A., Jouad, H., in press. Phytotherapy in Tafilalet region. Revue of Tafilalet Association. Fifth Medical Caravan.
5. El Bahri L., Djegham M., Bellil H. Retama raetam W: a poisonous plant of North Africa. Veterinary and Human Toxicology. 41:1999;33-35.
6. Jensen T., Stender S., Deckert T. Abnormalities in plasma concentrations of lipoprotein and fibrinogen in type 1 (insulin-dependent) diabetic patients with increased urinary albumin excretion. Diabetologia. 31:1988;142-145.
7. Kassem M., Mosharrafa S.A., Saleh N.A., Abdel-Wahab S.M. Two flavonoids from Retama raetam. Fitoterapia. 71:2000;649-659.
8. Kritchevsky D. Dietary protein, cholesterol and atherosclerosis: a review of the early history. Journal of Nutrition. 125:1995;589S-593S.
9. Maghrani M., Lemhadri A., Jouad H., Michel J.-B., Eddouks M. Effect of the desert plant Retama raetam on glycaemia in normal and streptozotocin- induced diabetic rats. Journal of Ethnopharmacology. 87:2003a;21-25.
10. Maghrani, M., Lemhadri, A., Zeggwagh, N.A., Jouad, H., Haloui, M., Eddouks, M., 2003b. Glucose lowering activity of Retama raetam in streptozotocin-induced diabetic rats. Phytotherapy Research. In press.
11. Mittler R., Merquiol E., Hallak-Herr E., Rachmilevitch S., Kaplan A., Cohen M. Living under a "dormant" canopy: a molecular acclimation mechanism of the desert plant Retama raetam. The Plant Journal. 25:2001;407-416.
12. Motta M., Giugno I., Bosco S., Pistone G., Ruello P., Maugeri D., Malaguarnera M. Serum lipoprotein(a) changes in acute myocardial infraction. Panminevra Medicine. 43:2001;77-80.
13. Pnueli L., Hallak-herr E., Rozenberg M., Cohen M., Goloubinoff P., Kaplan A., Mittler R. Molecular and biochemical mechanisms associated with dormancy and drought tolerance in the desert legume Retama raetam. The Plant Journal. 31:2002;319-330.
14. Reaven G.M. Banting lecture 1988: role of insulin resistance in human disease. Diabetes. 37:1988;1595-1607.
15. Ross R. The pathogenesis of atherosclerosis. New England Journal of Medicine. 314:1986;488-500.
16. Trejo-Gonzàlez A., Gabriel-Ortiz G., Puebla-Pérez A.M., Huizar-Contreras M.D., Munguia-Mazariegos M.D.R., Mejia-Arregum S., Calva E. A purified extract from prickly pear cactus (Opuntica fuliginosa) controls experimentally induced diabetes in rats. Journal of Ethnopharmacology. 55:1996;27-33.